Trial intelligence / Profile preview

Effects of testosterone treatment on endothelial function among transgender men

TCTR20240709003Unknown

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of testosterone in gender dysphoria (GD), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Endothelial function. Status: unknown.

02

Drugs

testosterone
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on TCTR20240709003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240709003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call